Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/17/2024 | Speculative Buy | Canaccord Genuity | ||
4/5/2024 | $2.25 → $2.75 | Neutral | Alliance Global Partners | |
3/20/2024 | Outperform → Perform | Oppenheimer | ||
2/9/2024 | Hold → Buy | Canaccord Genuity | ||
5/10/2023 | $4.25 → $4.75 | Hold → Buy | Craig Hallum | |
4/4/2023 | Underperform → Mkt Perform | Bernstein | ||
11/2/2022 | $3.90 | Mkt Perform | Bernstein | |
11/2/2022 | $3.00 | Mkt Perform | Bernstein |
Canaccord Genuity resumed coverage of SNDL Inc. with a rating of Speculative Buy
Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously
Oppenheimer downgraded GrowGeneration from Outperform to Perform
PORTLAND, Ore., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Today, The Shock Top Company, a subsidiary of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), proudly announces a new partnership with Mizzou Athletics as the official craft beer sponsor of the University of Missouri Tigers. Now, Tigers fans can look forward to the zesty taste of Shock Top beer as a staple in their game day experience. Prinz Pinakatt, Chief Marketing Officer at Tilray Beverages said, "Mizzou fans are known for their unwavering loyalty and spirited support, making them the perfect community to embrace our brand. This partnership is about becoming a part of the gameday traditions that Mizzou fans hold dear. Whether they're t
IGC-AD1 demonstrates the potential to modify tau and improve spatial memory Data supports the initiation of clinical trials investigating IGC-AD1 as a treatment for Alzheimer's disease IGC Pharma, Inc. (NYSE:IGC) ("IGC Pharma" or the "Company") today announced data that reinforces the therapeutic potential of IGC-AD1 as a disease-modifying treatment for Alzheimer's disease. The data highlights IGC-AD1's promising effects on tau tangles and spatial memory. These results build on earlier data demonstrating IGC-AD1's potential to reduce amyloid plaque. IGC Pharma's findings from preclinical Alzheimer's cell line studies have revealed IGC-AD1's significant impact on tau pathology. The data s
NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray Brands") (NASDAQ:TLRY, TSX:TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the launch of Redecan EU-GMP certified medical cannabis products in Australia. Denise Faltischek, Chief Strategy Officer and Head of International, Tilray Brands, said, "The launch of Redecan, a premium cannabis brand, in Australia is another significant milestone for Tilray Medical, as we relentlessly pursue our vision of making high-quality medical cannabis produ
Focused on supporting licensed cannabis retailers in New York, this collaboration highlights Leafly's dedication to supporting local, legal cannabis businesses in the Empire State Leafly (NASDAQ:LFLY), one of the world's leading cannabis discovery marketplaces and trusted educational resources, is expanding its support of the legal New York cannabis market with a new alliance with the New York Cannabis Retail Association (NYCRA), a non-profit coalition of New York dispensary owners united under the slogan ‘Collaboration Over Competition.' The partnership aims to help create a more sustainable, equitable, and inclusive cannabis industry. Together, Leafly and NYCRA will sponsor a series of
TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing on sustainable profitability. "We are thrilled to welcome Shmulik to our Board of Directors," said Oren Shuster, Chief Executive Officer of
Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline on September 20, 2024 at 1:00 p.m. (Eastern time) Company Releases Q&A About Annual Meeting Quorum Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at [email protected] SMITHS FALLS, ON, Sept. 11, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today urges its shareholders to vote ahead of the upcoming annual general meeting of shareholders (the "Meeting") on September 24, 2024 at 1:00 pm (Eastern time). The Board of Directors of Canopy Growth recommends shareho
SC 13D/A - IGC Pharma, Inc. (0001326205) (Subject)
SC 13D - IGC Pharma, Inc. (0001326205) (Subject)
SC 13D/A - Cronos Group Inc. (0001656472) (Subject)
Under the new license, Aurora may also cultivate an approved additional product, and plans to expand their offerings to the rapidly growing German patient base. Aurora will also receive a dedicated R&D license, allowing for the trial of up to seven additional novel cultivars at the company's local EU GMP facility in Leuna, Germany.
California's Glass House Reappoints Board Member As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors investors and leaders in the cannabis industry, let’s scroll through the latest leadership changes in the space. Get your tickets now before prices surge by following this link. Long Beach, California-based vertically-integrated cannabis company Glass House Brands Inc. (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX:GLASF) (OTCQX:GHBWF) announced last week the reappointment of Hector De La Torre to its board of directors. De La Torre previously served as an original member of the board until 2023. At the time, he s
GrowGeneration Corp. (NASDAQ:GRWG), one of the nation’s top providers of hydroponic and organic gardening products, announced certain preliminary unaudited results Monday for the second quarter of 2024, alongside a strategic restructuring plan aimed at boosting profitability. The company’s net revenue is projected to surpass $53 million, marking a 10.6% increase from the previous quarter’s $47.9 million. Restructuring Plan Targets $12 Million Savings The restructuring plan is designed to save approximately $12 million over the next year. Key areas of focus include enhancing proprietary brands, digital transformation and streamlining operations. GrowGeneration aims for proprietary brand
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Aug. 23, 2024 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that
IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO and GLIL YAM, Israel, Aug. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended June 30, 2023, unless otherwise stated. Q2 2024 Financial Highlights 12% Revenue increase to $14.8M vs. $13.2M in Q2 2023 129% increase in IMC Germany sales vs. Q2 2023 to $3.5M. IMC Germany sales now make up 24% of the entire Company r
Focus on profitable revenue generation delivered 67% increase in gross profit year-over-year Record quarter for Canada Medical Cannabis with Net Revenue increasing 20% year-over-year and 6th consecutive quarter of growth Extended maturity of senior secured term loan to December 18, 2026 with an option to further extend to September 18, 2027 SMITHS FALLS, ON, Aug. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the first quarter ended June 30, 2024 ("Q1 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
20-F/A - IM Cannabis Corp. (0001792030) (Filer)
PRE 14A - Tilray Brands, Inc. (0001731348) (Filer)
8-K - Tilray Brands, Inc. (0001731348) (Filer)
4 - Cronos Group Inc. (0001656472) (Issuer)
4 - GrowGeneration Corp. (0001604868) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)